Survey of human antibody responses to influenza virus matrix protein 2 by use of a sensitive flow cytometric method

Journal of Infectious Diseases

Volumn 209, Issue 7, 2014, Pages 975-977

  Epstein, Suzanne L ^a   García, Mayra ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

flow cytometry; human antibodies; influenza; matrix 2; pandemic; seasonal

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; MATERNAL ANTIBODY; MATRIX PROTEIN; MATRIX PROTEIN 1; MATRIX PROTEIN 2; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H7N9; NONHUMAN; NOTE; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS REPLICATION; WESTERN BLOTTING;

FLOW CYTOMETRY; HUMAN ANTIBODIES; INFLUENZA; MATRIX 2; PANDEMIC; SEASONAL;

ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; VIRAL MATRIX PROTEINS;

EID: 84898930702     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit813     Document Type: Note

References (17)

1. Epstein SL, Price GE. Cross-protective immunity to influenza A viruses. Expert Rev Vaccines 2010; 9:1325-41
2. Zebedee SL, Lamb RA. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988; 62:2762-72
3. Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990; 64:1375-7. (Pubitemid 20087784
4. Fan J, Liang X, Horton MS, et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004; 22:2993-3003. (Pubitemid 39037199
5. Mozdzanowska K, Feng JQ, Eid M, et al. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003; 21:2616-26. (Pubitemid 36561354
6. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 1995; 13:1399-402
7. De Filette M, Martens W, Roose K, et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem 2008; 283:11382-7
8. Liu WL, Zou P, Liu ZQ, Yun L, Jian D, Chen YH. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 2004; 23:366-71
9. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Med 1999; 5:1157-63. (Pubitemid 29474420
10. Tompkins SM, Zhao ZS, Lo C-Y, et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007; 13: 426-35. (Pubitemid 46348126
11. http://clinicaltrials.gov/ct2/show/results/NCT 00819013?term= M2+influenza+vaccine&rank =1§=Xa015#outcome5. 2012. Accessed 30 December 2013
12. Black RA, Rota PA, Gorodkova N, Klenk HD, Kendal AP. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol 1993; 74:143-6. (Pubitemid 23053779
13. Feng JQ, Zhang MX, Mozdzanowska K, et al. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 2006; 3:102
14. Zhong W, He J, Tang X, et al. Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses. J Immunol Methods 2011; 369:115-24
15. Sridhar S, Begom S, Bermingham A, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 2013; 19:1305-12
16. Murphy BR, Kasel JA, Chanock RM. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 1972; 286:1329-32
17. Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-Type virus. J Clin Microbiol 1986; 24:157-60. (Pubitemid 16090261